GB9919597D0 - Methods and compositions for diagnosis of hepatoma - Google Patents

Methods and compositions for diagnosis of hepatoma

Info

Publication number
GB9919597D0
GB9919597D0 GBGB9919597.6A GB9919597A GB9919597D0 GB 9919597 D0 GB9919597 D0 GB 9919597D0 GB 9919597 A GB9919597 A GB 9919597A GB 9919597 D0 GB9919597 D0 GB 9919597D0
Authority
GB
United Kingdom
Prior art keywords
hepatoma
diagnosis
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9919597.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Priority to GBGB9919597.6A priority Critical patent/GB9919597D0/en
Publication of GB9919597D0 publication Critical patent/GB9919597D0/en
Priority to PCT/GB2000/003224 priority patent/WO2001013118A2/en
Priority to AU67096/00A priority patent/AU6709600A/en
Priority to US10/079,596 priority patent/US20030077603A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB9919597.6A 1999-08-18 1999-08-18 Methods and compositions for diagnosis of hepatoma Ceased GB9919597D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9919597.6A GB9919597D0 (en) 1999-08-18 1999-08-18 Methods and compositions for diagnosis of hepatoma
PCT/GB2000/003224 WO2001013118A2 (en) 1999-08-18 2000-08-18 Methods and compositions for diagnosis of hepatoma
AU67096/00A AU6709600A (en) 1999-08-18 2000-08-18 Methods and compositions for diagnosis of hepatoma
US10/079,596 US20030077603A1 (en) 1999-08-18 2002-02-19 Methods and compositions for diagnosis of hepatoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9919597.6A GB9919597D0 (en) 1999-08-18 1999-08-18 Methods and compositions for diagnosis of hepatoma

Publications (1)

Publication Number Publication Date
GB9919597D0 true GB9919597D0 (en) 1999-10-20

Family

ID=10859407

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9919597.6A Ceased GB9919597D0 (en) 1999-08-18 1999-08-18 Methods and compositions for diagnosis of hepatoma

Country Status (3)

Country Link
AU (1) AU6709600A (en)
GB (1) GB9919597D0 (en)
WO (1) WO2001013118A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004055519A2 (en) * 2002-12-17 2004-07-01 Sinogenomax Co. Ltd. Specific markers for pancreatic cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4558004A (en) * 1983-03-25 1985-12-10 The Regents Of The University Of California Monitoring preneoplastic antigen
JPH06105257B2 (en) * 1984-08-07 1994-12-21 協和メデックス株式会社 Cancer measurement kit
JP2579497B2 (en) * 1987-09-07 1997-02-05 オリエンタル酵母工業株式会社 Liver disease diagnostic agent
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
US5175083A (en) * 1989-07-24 1992-12-29 Board Of Regents, University Of Texas Immunoassay for the quantitation of human C4 gene products
US5731168A (en) * 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
AU2480799A (en) * 1998-01-29 1999-08-16 Thomas Jefferson University Molecular markers for diagnosing hepatocellular carcinoma
EP1055126A1 (en) * 1998-02-13 2000-11-29 Oxford GlycoSciences (UK) Limited Methods and compositions for diagnosis of hepatoma

Also Published As

Publication number Publication date
AU6709600A (en) 2001-03-13
WO2001013118A3 (en) 2002-01-17
WO2001013118A2 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
HK1048247A1 (en) Stable carotene-xanthophyll beadlet compositions and methods of use
EP1227821A4 (en) Therapeutic compositions and methods of use thereof
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
GB9909966D0 (en) Analysis of fundus images
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
HUP0201872A3 (en) Steroid compounds and pharmaceutical compositions of the same
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
EP1180006A4 (en) Compositions and methods for their preparation from lepidium
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
EP1163340A4 (en) Compositions and methods for the modification of gene expression
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
GB9919597D0 (en) Methods and compositions for diagnosis of hepatoma
AU2001255580A1 (en) Methods and compositions for the diagnosis of schizophrenia
EP1233978A4 (en) Compositions and methods for the improved diagnosis and treatment of germ cell tumors
GB9803138D0 (en) Methods and compositions for diagnosis of hepatoma
GB9803269D0 (en) Methods And Compositions For Diagnosis Of Hepatoma
AU2001257164A1 (en) Methods and compositions for the diagnosis of schizophrenia
HK1046019A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
SI1471926T1 (en) Compositions and methods for the therapeutic use of an atonal-associated sequence
GB9915881D0 (en) Methods of diagnosis
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)